Mirae Asset Global ETFs Holdings’s Mirum Pharmaceuticals MIRM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.98M	Buy	25,277 +2,008	+9%	+$202K	﹤0.01%	1062
2026 Q1	$2.13M	Sell	23,269 -23	-0.1%	-$2.16K	﹤0.01%	1145
2025 Q4	$1.84M	Buy	23,292 +2,848	+14%	+$204K	﹤0.01%	1188
2025 Q3	$1.5M	Sell	20,444 -5,200	-20%	-$331K	﹤0.01%	1276
2025 Q2	$1.31M	Sell	25,644 -403	-2%	-$17.9K	﹤0.01%	1307
2025 Q1	$1.18M	Buy	26,047 +1,720	+7%	+$81.1K	﹤0.01%	1415
2024 Q4	$1.01M	Sell	24,327 -498	-2%	-$20.8K	﹤0.01%	1538
2024 Q3	$968K	Buy	24,825 +9,217	+59%	+$368K	﹤0.01%	1557
2024 Q2	$531K	Buy	+15,608	New	+$409K	﹤0.01%	1796

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's MIRM Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Mirum Pharmaceuticals (MIRM) stake by 8.6% in Q2 2026, buying an estimated $202K and bringing the position to 25,277 shares worth $2.98M. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Mirae Asset Global ETFs Holdings first reported a position in MIRM in Q2 2024 and has held it in 9 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Mirae Asset Global ETFs Holdings held 25,277 shares of Mirum Pharmaceuticals worth $2.98M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 2,008 Mirum Pharmaceuticals shares in Q2 2026, an estimated $202K.
Mirum Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1062 holding.
Mirae Asset Global ETFs Holdings first reported a position in Mirum Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.